Vertex Pharmaceuticals Inc (VRTX)
411.09
+3.28
(+0.80%)
USD |
NASDAQ |
Mar 18, 16:00
411.09
0.00 (0.00%)
After-Hours: 20:00
Vertex Pharmaceuticals Price: 411.09 for March 18, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 15, 2024 | 410.10 | 411.64 | 406.97 | 407.81 | 1.169M |
Mar 14, 2024 | 414.01 | 414.98 | 407.08 | 408.77 | 1.031M |
Mar 13, 2024 | 414.46 | 415.92 | 410.39 | 413.20 | 764712.0 |
Mar 12, 2024 | 413.00 | 416.11 | 409.02 | 412.45 | 888995.0 |
Mar 11, 2024 | 414.00 | 416.70 | 409.52 | 414.47 | 1.263M |
Mar 08, 2024 | 412.34 | 416.25 | 410.94 | 413.59 | 814943.0 |
Mar 07, 2024 | 415.14 | 418.32 | 410.23 | 410.54 | 923326.0 |
Mar 06, 2024 | 414.23 | 418.22 | 410.46 | 411.85 | 1.223M |
Mar 05, 2024 | 424.87 | 425.49 | 414.04 | 415.44 | 1.124M |
Mar 04, 2024 | 432.73 | 433.99 | 422.16 | 424.03 | 1.121M |
Mar 01, 2024 | 423.20 | 433.67 | 422.95 | 432.76 | 1.102M |
Feb 29, 2024 | 429.18 | 429.18 | 420.24 | 420.74 | 1.849M |
Feb 28, 2024 | 429.60 | 433.49 | 425.71 | 426.97 | 786555.0 |
Feb 27, 2024 | 434.13 | 437.00 | 430.52 | 430.92 | 917364.0 |
Feb 26, 2024 | 425.70 | 434.26 | 425.70 | 433.48 | 787961.0 |
Feb 23, 2024 | 430.00 | 434.50 | 429.07 | 430.11 | 749859.0 |
Feb 22, 2024 | 419.85 | 429.80 | 419.85 | 426.78 | 1.092M |
Feb 21, 2024 | 421.77 | 424.00 | 414.80 | 419.63 | 916847.0 |
Feb 20, 2024 | 420.79 | 425.00 | 416.16 | 420.64 | 1.056M |
Feb 16, 2024 | 427.04 | 427.04 | 420.97 | 422.20 | 1.190M |
Feb 15, 2024 | 419.16 | 427.41 | 418.61 | 426.29 | 1.474M |
Feb 14, 2024 | 418.38 | 420.45 | 414.26 | 417.88 | 1.133M |
Feb 13, 2024 | 417.36 | 419.42 | 412.77 | 416.04 | 1.164M |
Feb 12, 2024 | 420.24 | 421.30 | 415.28 | 418.53 | 1.368M |
Feb 09, 2024 | 425.96 | 425.96 | 419.51 | 422.91 | 1.169M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
164.61
Minimum
May 13 2019
446.08
Maximum
Jan 30 2024
260.74
Average
248.52
Median
Mar 16 2022
Price Benchmarks
Amgen Inc | 270.88 |
Eli Lilly and Co | 762.66 |
Regeneron Pharmaceuticals Inc | 960.52 |
Moderna Inc | 104.28 |
Pfizer Inc | 27.74 |
Price Related Metrics
PE Ratio | 29.60 |
PS Ratio | 10.85 |
PEG Ratio | 3.582 |
Price to Book Value | 6.040 |
Price to Free Cash Flow | 32.66 |
Earnings Yield | 3.38% |
Market Cap | 106.19B |
PEGY Ratio | 3.582 |
Operating PE Ratio | 24.86 |
Normalized PE Ratio | 26.80 |